{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:37:21Z","timestamp":1791333441324,"version":"4.3.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Mitochondrial neurogastrointestinal encephalomyopathy is a rare multisystemic autosomic recessive disorder characterized by: onset typically before the age of 30 years; ptosis; progressive external ophthalmoplegia; gastrointestinal dysmotility; cachexia; peripheral neuropathy; and leucoencephalopathy. The disease is caused by mutations in the TYMP gene encoding thymidine phosphorylasethymine phosphorylase. Anecdotal reports suggest that allogeneic haematopoetic stem cell transplantation may be beneficial for mitochondrial neurogastrointestinal encephalomyopathy, but is associated with a high mortality. After selecting patients who fulfilled the clinical criteria for mitochondrial neurogastrointestinal encephalomyopathy and had severe thymidine phosphorylase deficiency in the buffy coat (&amp;lt;10% of normal activity), we reviewed their medical records and laboratory studies. We identified 102 patients (50 females) with mitochondrial neurogastrointestinal encephalomyopathy and an average age of 32.4 years (range 11\u201359 years). We found 20 novel TYMP mutations. The average age-at-onset was 17.9 years (range 5 months to 35 years); however, the majority of patients reported the first symptoms before the age of 12 years. The patient distribution suggests a relatively high prevalence in Europeans, while the mutation distribution suggests founder effects for a few mutations, such as c.866A&amp;gt;G in Europe and c.518T&amp;gt;G in the Dominican Republic, that could guide genetic screening in each location. Although the sequence of clinical manifestations in the disease varied, half of the patients initially had gastrointestinal symptoms. We confirmed anecdotal reports of intra- and inter-familial clinical variability and absence of genotype\u2013phenotype correlation in the disease, suggesting genetic modifiers, environmental factors or both contribute to disease manifestations. Acute medical events such as infections often provoked worsening of symptoms, suggesting that careful monitoring and early treatment of intercurrent illnesses may be beneficial. We observed endocrine\/exocrine pancreatic insufficiency, which had not previously been reported. Kaplan\u2013Meier analysis revealed significant mortality between the ages of 20 and 40 years due to infectious or metabolic complications. Despite increasing awareness of this illness, a high proportion of patients had been misdiagnosed. Early and accurate diagnosis of mitochondrial neurogastrointestinal encephalomyopathy, together with timely treatment of acute intercurrent illnesses, may retard disease progression and increase the number of patients eligible for allogeneic haematopoetic stem cell transplantation.<\/jats:p>","DOI":"10.1093\/brain\/awr245","type":"journal-article","created":{"date-parts":[[2011,9,21]],"date-time":"2011-09-21T00:52:03Z","timestamp":1316566323000},"page":"3326-3332","source":"Crossref","is-referenced-by-count":183,"title":["Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy"],"prefix":"10.1093","volume":"134","author":[{"given":"Caterina","family":"Garone","sequence":"first","affiliation":[{"name":"1 Department of Neurology, Columbia University Medical Centre, New York, NY 10032, USA"},{"name":"2 Human Genetics Joint PhD Programme, University of Turin, 10125 Turin, Italy and University of Bologna, 40125 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Tadesse","sequence":"first","affiliation":[{"name":"1 Department of Neurology, Columbia University Medical Centre, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Hirano","sequence":"first","affiliation":[{"name":"1 Department of Neurology, Columbia University Medical Centre, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,9,20]]},"reference":[{"key":"2020022707432498900_awr245-B1","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"key":"2020022707432498900_awr245-B2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.pediatrneurol.2004.05.009","article-title":"Paralytic ileus in MELAS with phenotypic features of MNGIE","volume":"31","author":"Chang","year":"2004","journal-title":"Pediatr Neurol"},{"key":"2020022707432498900_awr245-B3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.yjmcc.2009.02.011","article-title":"Evidence for nuclear modifier gene in mitochondrial cardiomyopathy","volume":"46","author":"Davidson","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"2020022707432498900_awr245-B4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(95)11622-4","article-title":"Neurons of the peripheral nervous system express thymidine phosphorylase","volume":"192","author":"Eccleston","year":"1995","journal-title":"Neurosci Lett"},{"key":"2020022707432498900_awr245-B5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/path.1711760212","article-title":"Platelet-derived endothelial cell growth factor\/thymidine phosphorylase expression in normal tissue: an immunohistochemical study","volume":"176","author":"Fox","year":"1995","journal-title":"J Pathol"},{"key":"2020022707432498900_awr245-B6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/bmt.2010.100","article-title":"Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach","volume":"46","author":"Halter","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"2020022707432498900_awr245-B7","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/01.wnl.0000240853.97716.24","article-title":"Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE","volume":"67","author":"Hirano","year":"2006","journal-title":"Neurology"},{"key":"2020022707432498900_awr245-B8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.nrl.0000106919.06469.04","article-title":"MNGIE: a disease of two genomes","volume":"10","author":"Hirano","year":"2004","journal-title":"Neurologist"},{"key":"2020022707432498900_awr245-B9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1212\/WNL.44.4.721","article-title":"Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder","volume":"44","author":"Hirano","year":"1994","journal-title":"Neurology"},{"key":"2020022707432498900_awr245-B10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/301979","article-title":"Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome maps to chromosome 22q13.32-qter","volume":"63","author":"Hirano","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2020022707432498900_awr245-B11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.clineuro.2007.04.008","article-title":"A novel ECGF1 mutation in a Thai patient with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)","volume":"109","author":"Kintarak","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"2020022707432498900_awr245-B12","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/01.wnl.0000239824.95411.52","article-title":"Infusion of platelets transiently reduces nucleoside overload in MNGIE","volume":"67","author":"Lara","year":"2006","journal-title":"Neurology"},{"key":"2020022707432498900_awr245-B13","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/hmg\/ddn401","article-title":"Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase deficient mice","volume":"18","author":"L\u00f3pez","year":"2009","journal-title":"Hum Mol Genet"},{"key":"2020022707432498900_awr245-B14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0006-291X(03)00294-8","article-title":"Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency","volume":"303","author":"Mart\u00ed","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"2020022707432498900_awr245-B15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1373\/clinchem.2003.026179","article-title":"Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays","volume":"50","author":"Marti","year":"2004","journal-title":"Clin Chem"},{"key":"2020022707432498900_awr245-B16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.20615","article-title":"Late-onset MNGIE due to partial loss of thymidine phosphorylase activity","volume":"58","author":"Mart\u00ed","year":"2005","journal-title":"Ann Neurol"},{"key":"2020022707432498900_awr245-B17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-4889(96)00078-X","article-title":"Tissue distribution of human gliostatin\/platelet-derived endothelial cell growth factor (PD-ECGF) and its drug-induced expression","volume":"1314","author":"Matsukawa","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"2020022707432498900_awr245-B18","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI17828","article-title":"Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency","volume":"111","author":"Nishigaki","year":"2003","journal-title":"J Clin Invest"},{"key":"2020022707432498900_awr245-B19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/hmg\/ddh010","article-title":"ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy","volume":"13","author":"Nishigaki","year":"2004","journal-title":"Hum Mol Genet"},{"key":"2020022707432498900_awr245-B20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.283.5402.689","article-title":"Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder","volume":"283","author":"Nishino","year":"1999","journal-title":"Science"},{"key":"2020022707432498900_awr245-B21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0960-8966(00)00159-0","article-title":"MNGIE: from nuclear DNA to mitochondrial DNA","volume":"11","author":"Nishino","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"2020022707432498900_awr245-B22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/1531-8249(200006)47:6<792::AID-ANA12>3.0.CO;2-Y","article-title":"MNGIE: an autosomal recessive disorder due to thymidine phosphorylase mutations","volume":"47","author":"Nishino","year":"2000","journal-title":"Ann Neurol"},{"key":"2020022707432498900_awr245-B23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(76)90236-7","article-title":"Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria","volume":"27","author":"Okamura","year":"1976","journal-title":"J Neurol Sci"},{"key":"2020022707432498900_awr245-B24","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1212\/WNL.51.4.1086","article-title":"Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome","volume":"51","author":"Papadimitriou","year":"1998","journal-title":"Neurology"},{"key":"2020022707432498900_awr245-B25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/RCT.0b013e3181c71d48","article-title":"Multiple cranial nerve enhancement in mitochondrial neurogastrointestinal encephalomyopathy","volume":"34","author":"Petcharunpaisan","year":"2010","journal-title":"J Comput Assist Tomogr"},{"key":"2020022707432498900_awr245-B26","doi-asserted-by":"crossref","first-page":"22720","DOI":"10.1074\/jbc.M604498200","article-title":"Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)","volume":"281","author":"Pontarin","year":"2006","journal-title":"J Biol Chem"},{"key":"2020022707432498900_awr245-B27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.bbadis.2009.08.016","article-title":"Collated mutations in mitochondrial DNA (mtDNA) depletion syndrome (excluding the mitochondrial gamma polymerase, POLG1)","volume":"1792","author":"Poulton","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2020022707432498900_awr245-B28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00415-005-0712-4","article-title":"Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation","volume":"252","author":"Said","year":"2005","journal-title":"J Neurol"},{"key":"2020022707432498900_awr245-B29","first-page":"332","article-title":"Allogeneic hematopoetic stem cell transplantation (HSCT) for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)","volume":"73","author":"Sch\u00fcpbach","year":"2009","journal-title":"Neurology"},{"key":"2020022707432498900_awr245-B30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00415-006-0255-3","article-title":"Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features","volume":"254","author":"Sch\u00fcpbach","year":"2007","journal-title":"J Neurol"},{"key":"2020022707432498900_awr245-B31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/archneurol.2009.139","article-title":"Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B","volume":"66","author":"Shaibani","year":"2009","journal-title":"Arch Neurol"},{"key":"2020022707432498900_awr245-B32","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1074\/jbc.M111028200","article-title":"Altered thymidine metabolism due to defects of thymidine phosphorylase","volume":"277","author":"Spinazzola","year":"2002","journal-title":"J Biol Chem"},{"key":"2020022707432498900_awr245-B33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jmg.2003.013789","article-title":"MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation","volume":"41","author":"Szigeti","year":"2004","journal-title":"J Med Genet"},{"key":"2020022707432498900_awr245-B34","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1016\/j.febslet.2007.06.042","article-title":"Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)","volume":"581","author":"Valentino","year":"2007","journal-title":"FEBS Lett"},{"key":"2020022707432498900_awr245-B35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.ejhg.5201002","article-title":"Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy","volume":"11","author":"Van Goethem","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"2020022707432498900_awr245-B36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-5793(92)81428-O","article-title":"Platelet-derived endothelial cell growth factor. Pharmacokinetics, organ distribution and degradation after intravenous administration in rats","volume":"313","author":"Waltenberger","year":"1992","journal-title":"FEBS Lett"},{"key":"2020022707432498900_awr245-B37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-4165(90)90160-X","article-title":"Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors","volume":"1034","author":"Yoshimura","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"2020022707432498900_awr245-B38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2982.2009.01264.x","article-title":"Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy","volume":"21","author":"Zimmer","year":"2009","journal-title":"Neurogastroenterol Motil"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/134\/11\/3326\/32674842\/awr245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/134\/11\/3326\/32674842\/awr245.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T12:43:38Z","timestamp":1582807418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/134\/11\/3326\/312918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,20]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,9,20]]},"published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awr245","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,11]]},"published":{"date-parts":[[2011,9,20]]}}}